분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-04-10 17:21:15 , Hit : 865
 Hitting HIV with CRISPR/Cas9 Can Arouse Resistance

GEN News Highlights

Apr 8, 2016

Click Image To Enlarge +

  

This visual abstract depicts how HIV-1 can escape Cas9/sgRNA-mediated inhibition. The researchers reveal that the NHEJ repair machinery generates mutations in the HIV-1 Cas9 cleavage site that result in two outcomes: viral replication suppression and viral escape. [Wang et al./Cell Reports]


Stretches of DNA altered by the human immunodeficiency virus (HIV) can be targeted by the CRISPR/Cas9 endonuclease system, resulting in strategically placed cuts, imperfect repairs to those cuts, and—finally—the end of viral replication. But in some cases, the battle-scarred DNA that CRISPR/Cas9 leaves behind won’t give up the fight. Worse, this DNA becomes harder to recognize, by dint of its scars, and becomes even more dangerous. It acquires a form of resistance, the ability to duck renewed attacks from CRISPR/Cas9.

This finding emerged from a study carried out by an international team of scientists that represented McGill University, the University of Montreal, the Chinese Academy of Medical Sciences, and Peking Union Medical College. These scientists, led by McGill’s Chen Liang, Ph.D., found that when CRISPR/Cas9 is used to mutate HIV-1 within cellular DNA, two outcomes are possible: (1) inactivation of HIV-1 and (2) acceleration of viral escape. This finding, the researchers cautioned, potentially limits the use of CRISPR/Cas9 in HIV-1 therapy.

The researchers also sounded an optimistic note. They pointed to strategies that could help overcome HIV’s tendency to escape CRISPR/Cas9’s antiviral action. For example, targeting multiple sites with CRISPR/Cas9 or using other enzymes aside from Cas9. Once a solution is identified, the next barrier will be identifying ways to deliver the treatment to patients.

The research team’s work appeared April 7 in the journal Cell Reports, in an article entitled, “CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.” The article emphasized the importance of the CRISPR/Cas9 system’s reliance on single guide RNA (sgRNA), the programmable element of the system that allows DNA to be cleaved at specific sequences.

“Using HIV-1, we have now demonstrated that many of [CRISPR/Cas9-derived mutations or indels] are indeed lethal for the virus, but that others lead to the emergence of replication competent viruses that are resistant to Cas9/sgRNA,” wrote the article’s authors. “This unexpected contribution of Cas9 to the development of viral resistance is facilitated by some indels that are not deleterious for viral replication, but that are refractory to recognition by the same sgRNA as a result of changing the target DNA sequences.”

The authors added that indels that are compatible with viral viability should be taken into consideration if Cas9/sgRNA is used to treat virus infection and genetic diseases. They expect that such indels would contribute to virus escape not only when Cas9/sgRNA is utilized to control new infections, but also in the context of eliminating latent viral DNA of herpes viruses, hepatitis B virus (HBV), and HIV, among others.

"CRISPR/Cas9 gives a new hope toward finding a cure, not just for HIV-1, but for many other viruses," said Dr. Liang. "We have a long road toward the goal, and there may be many barriers and limitations that we need to overcome, but we're confident that we will find success."







947   바이오통신원 [바이오토픽] 이제는 염기편집 시대, Cas9를 변형하여 DNA 한 글자만 바꾼다.  이성욱 2016/04/21 1171
  Hitting HIV with CRISPR/Cas9 Can Arouse Resistance  이성욱 2016/04/10 865
945   GSK Gets Positive CHMP Opinion For Strimvelis To Treat Rare Disease ADA-SCID  이성욱 2016/04/02 1036
944   CRISPR Can Tag RNA  이성욱 2016/03/26 800
943   미니멀세포(minimal cell)를 만든 크레이그 벤터  이성욱 2016/03/26 956
942   Minimal Genome Created  이성욱 2016/03/26 832
941   Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 774
940   RNA May Surpass DNA in Precision Medicine  이성욱 2016/03/23 821
939   Zika Update  이성욱 2016/03/15 755
938   CRISPR/Cas9을 이용하여 PRRS 바이러스에 감염되지 않는 돼지를 개발하다  이성욱 2016/03/14 1203
937   유전자 가위, 매머드 복원-안전한 백신의 시대 리본 자르다  이성욱 2016/03/14 989
936   Tunable Form of CRISPR Is an Efficient Regulator of Stem Cell Expression  이성욱 2016/03/14 700
935   NIH 연구진들은 5가지 종류의 암에서 공유되는 충격적인 게놈 상의 특징을 확인  이성욱 2016/03/09 829
934   특허전쟁: 미국 특허청, CRISPR의 특허권 중재 시작  이성욱 2016/03/08 1049
933   CRISPR Editing of Human Embryos Approved in the U.K.  이성욱 2016/02/02 808
932   CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 762
931   거대 바이러스에게서도 발견된 CRISPR 유사 시스템  이성욱 2016/03/02 1123
930   MIT 선정 2015년 주목받은 Biomedicine 뉴스  이성욱 2016/02/03 888
929   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1066
928   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1057

[이전 10개] [1]..[11][12][13][14][15][16] 17 [18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN